Carolinas Inc - Local Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Abbott Laboratories (NY: ABT)
36.59 USD  -0.24 (-0.65%)
Official Closing Price  /  Updated: 6:40 PM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about Abbott Laboratories
 
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Jim Cramer's Down and Out Turnaround Play
May 17, 2013
Cramer has been looking at long-term losers to see if any show potential. He's found something. Get all the details now. Read More
category Biotechnology , Boston Scientific Corp , tvcodes/tvearn , and 16 more.
from CNBC.com News
Cramer: Break-Up Could Boost This Stock 19%
May 17, 2013
Cramer's convinced the best way to for this health care company to maximize shareholder value is to break up. "It's a tried and true formula," insisted the Mad Money host. Read More
category Investing , Health Care/Health Care Equipment and Services/Health Care Equipment and Supplies/Health Care Equipm , Biotechnology , and 10 more.
from CNBC.com News
AbbVie (ABBV) Has Plenty More Tricks Up Its Sleeve - Barron's
May 17, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8349940 for the full story. Read More
from StreetInsider.com News Articles
Loeb's Third Point LLC Enters Anadarko (APC), NXP Semi (NXPI), Tiffany & Co. (TIF); Exits Herbalife (HLF), Morgan Stanley (MS)
May 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8344583 for the full story. Read More
from StreetInsider.com News Articles
Inova president: Health systems entering 'new normal' of fewer patients
May 14, 2013
category St/ Jude Medical , National Cancer Institute , Inova Health System , and 9 more.
from Business Journals
Alvine lands $70 million from AbbVie for celiac disease drug
May 14, 2013
category Health Care , Stanford University , Abhay Joshi , and 4 more.
from Business Journals
Lightning Round: Valero, Abbott Labs & More
May 13, 2013
Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites. Read More
category Lightning Round , Abbott Laboratories , Mad Money for Mobile , and 9 more.
from CNBC.com News
UCO, PERM: Big ETF Outflows
May 13, 2013
Turning today to week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, the largest outflow was seen in the Proshares Ultra DJ-UBS Crude Oil ETF (UCO), which shed... Read More
category ETFs
from ETF Channel
SSO, ABT, ADBE, ADT: Large Outflows Detected at ETF
May 13, 2013
Symbols mentioned in this story: SSO, ABT, ADBE, ADT Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... Read More
category ETFs
from ETF Channel
New Data On Boston Scientific’s Atrial Fibrillation ‘Watchman’ Device Could Lift Outlook
May 13, 2013
category Pharmaceuticals , Medical Devices & Supplies
from Trefis
Abbvie says Chief Scientific Officer John Leonard to retire
May 10, 2013
May 10 (Reuters) - AbbVie Inc's chief scientific officer will be retiring in the next few months and will be involved in the process of naming a successor, the pharmaceutical company said in a... Read More
category companyNews
from Reuters: Company News
Jury orders Abbott Labs to pay $2 million in Humira suit
May 10, 2013
category Delores Tietz , Legal Services , Public Companies , and 9 more.
from Business Journals
Jury orders Abbott Labs to pay $2 million in Humira suit
May 10, 2013
In the first Humira lawsuit to go to trial, a Cook County jury has ordered Abbott Laboratories to pay $2.24 million to the plaintiff. The jury entered a verdict in favor of plaintiff Milton Tietz on... Read More
from National Business News - Local Business News | bizjournals
Medtronic: A Look At The Spinal Division
May 10, 2013
category Pharmaceuticals , Medical Devices & Supplies
from Trefis
S&P Highlights Biotech ETFs
May 10, 2013
Bolstered by an accommodating Food & Drug Administration and promising recent clinical results for drugs aimed at treating conditions such as hepatitis C and multiple sclerosis, biotechnology stocks... Read More
category Benzinga , ETFs , PJP , and 22 more.
from Latest Articles from Benzinga.com
Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With The Lowest PEG Ratio
May 08, 2013
Below are the top drug manufacturers-major stocks on the NYSE in terms of PEG ratio. WuXi PharmaTech (Cayman) (NYSE: WX ) has a PEG ratio of 1.12. WuXi PharmaTech's trailing-twelve-month revenue is... Read More
category Benzinga , JNJ , WX , and 6 more.
from Latest Articles from Benzinga.com
Patient Investors Will Find The Right Prescription In Hospira
May 07, 2013
Hospira (HSP) operated as the hospital products business of Abbott Laboratories until it was spun off into a stand-alone entity in 2004. Today, the company manufactures generic specialty injectable... Read More
category NYSE:ABT , NYSE:HSP
from Forbes Real Time
Near Term Catalysts And High Insider Ownership Makes GTx An Attractive Buy
May 07, 2013
category Pharmaceuticals
from Trefis
Dividend Highlights/Lowlights for May 6
May 06, 2013
These were some of the biggest dividend stock performers on the upside and the downside in today’s market action. Highlights Icahn Enterprises L.P. (IEP) – up 7% Bank of America (BAC) – up 5% Textron... Read More
category txt , bx , etr , and 10 more.
from Dividend Daily
FDA warns on use of certain migraine drugs during pregnancy
May 06, 2013
May 6 (Reuters) - The U.S. Food and Drug Administration warned on the use of migraine drug valproate sodium in pregnant women as it could result in lower IQ scores in the baby. Read More
category companyNews
from Reuters: Company News
BSX, ABT, ZMH, and ETRM Under StockCall’s Microscope
May 02, 2013
from ACCESSWIRE
Illumina and Other Bargain Biotech Stocks Worth a Look Now
May 01, 2013
The research team at PropThink, which focuses on emerging growth companies in the health care sector, recently offered a list of bargain biotech stocks worth a look. The stocks that made the list... Read More
category SHPG , amgen , Benzinga , and 31 more.
from Latest Articles from Benzinga.com
Manufacturing growth slows in April
May 01, 2013
category Institute for Supply Management , Flow Dry Technology Inc/ , Process Equipment Co/ , and 7 more.
from Business Journals
Boston Scientific’s Earnings Show Improving Outlook
April 30, 2013
category Pharmaceuticals , Medical Devices & Supplies
from Trefis
Galectin Therapeutics Gets A Bid After Promising Results
April 30, 2013
Galectin Therapeutics Gets A Bid After Promising Results Yesterday was a big victory for Newton, Massachusetts-based Galectin Therapeutics (NASDAQ: GALT) following new data that was presented by the... Read More
category LJPC , Brian L/ Wilson , GALT
from Bio-Wire.Com
UPDATE 2-U.S. task force calls for routine HIV testing for all adults
April 29, 2013
CHICAGO, April 29 (Reuters) - An influential U.S. panel is calling for HIV screening for all Americans aged 15 to 65, regardless of whether they are considered to be at high risk, a change that may... Read More
category companyNews
from Reuters: Company News
'Ultimate' Stock Picker's Favorite Names
April 29, 2013
Robert Zagunis, named one of Moringstar's "Ultimate Stock-Pickers," shares three of his favorite companies. Read More
category tvfmwebex , Fast Money Halftime Report , Microsoft Corp , and 9 more.
from CNBC.com News
Bristol-Myers Squibb’s New Drugs Can Help Reverse Its Sinking Revenue
April 26, 2013
category Pharmaceuticals , Unassigned
from Trefis
UPDATE 3-AbbVie delivers on strong growth of Humira arthritis drug
April 26, 2013
April 26 (Reuters) - AbbVie Inc's quarterly profit rose 10 percent on surging sales of its Humira treatment for rheumatoid arthritis, and the company said it plans to launch several potentially... Read More
category companyNews
from Reuters: Company News
Humira Still Abbvie Story With Pipeline Chapter Ahead
April 26, 2013
In its first quarter as a standalone pharmaceutical company, AbbVie (ABBV) delivered as promised robust growth from its Humira biologic for myriad autoimmune diseases while Wall Street awaits some key... Read More
category NYSE:ABBV , NYSE:PFE , NYSE:ABT , and 1 more.
from Forbes Real Time
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here